Literature DB >> 17651457

Semiparametric inference for surrogate endpoints with bivariate censored data.

Debashis Ghosh1.   

Abstract

Considerable attention has been recently paid to the use of surrogate endpoints in clinical research. We deal with the situation where the two endpoints are both right censored. While proportional hazards analyses are typically used for this setting, their use leads to several complications. In this article, we propose the use of the accelerated failure time model for analysis of surrogate endpoints. Based on the model, we then describe estimation and inference procedures for several measures of surrogacy. A complication is that potentially both the independent and dependent variable are subject to censoring. We adapt the Theil-Sen estimator to this problem, develop the associated asymptotic results, and propose a novel resampling-based technique for calculating the variances of the proposed estimators. The finite-sample properties of the estimation methodology are assessed using simulation studies, and the proposed procedures are applied to data from an acute myelogenous leukemia clinical trial.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651457     DOI: 10.1111/j.1541-0420.2007.00834.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Evaluating surrogate marker information using censored data.

Authors:  Layla Parast; Tianxi Cai; Lu Tian
Journal:  Stat Med       Date:  2017-01-15       Impact factor: 2.373

2.  Meta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling.

Authors:  Debashis Ghosh; Jeremy M G Taylor; Daniel J Sargent
Journal:  Biometrics       Date:  2011-06-13       Impact factor: 2.571

3.  Assessing the value of a censored surrogate outcome.

Authors:  Layla Parast; Lu Tian; Tianxi Cai
Journal:  Lifetime Data Anal       Date:  2019-04-12       Impact factor: 1.588

4.  Estimation of the proportion of treatment effect explained by a high-dimensional surrogate.

Authors:  Ruixuan Rachel Zhou; Sihai Dave Zhao; Layla Parast
Journal:  Stat Med       Date:  2022-02-21       Impact factor: 2.497

5.  On assessing surrogacy in a single trial setting using a semicompeting risks paradigm.

Authors:  Debashis Ghosh
Journal:  Biometrics       Date:  2009-06       Impact factor: 2.571

6.  Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trials.

Authors:  Isabelle R Weir; Jennifer R Rider; Ludovic Trinquart
Journal:  Pharm Stat       Date:  2021-08-04       Impact factor: 1.894

7.  Allometric scaling patterns among the human coronary artery tree, myocardial mass, and coronary artery flow.

Authors:  Jin-Ho Choi; Eunsoo Kim; Hyung Yoon Kim; Seung-Hwa Lee; Sung Mok Kim
Journal:  Physiol Rep       Date:  2020-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.